Literature DB >> 776334

Editorial: BCG in cancer.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 776334      PMCID： PMC1640776     

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  15 in total

1.  Adjuvant immunotherapy with BCG in treatment of regional-lymph-node metastases from malignant melanoma.

Authors:  F R Eilber; D L Morton; E C Holmes; F C Sparks; K P Ramming
Journal:  N Engl J Med       Date:  1976-01-29       Impact factor: 91.245

2.  Mechanism of immunologically specific killing of tumour cells by macrophages.

Authors:  R Evans; P Alexander
Journal:  Nature       Date:  1972-03-24       Impact factor: 49.962

Review 3.  BCG and cancer (first of two parts).

Authors:  R C Bast; B Zbar; T Borsos; H J Rapp
Journal:  N Engl J Med       Date:  1974-06-20       Impact factor: 91.245

4.  Macrophage nonimmunologic recognition: target cell factors related to contact inhibition.

Authors:  J B Hibbs
Journal:  Science       Date:  1973-05-25       Impact factor: 47.728

5.  Tumor-specific vaccine containing Mycobacterium bovis and tumor cells: safety and efficacy.

Authors:  G L Bartlett; B Zbar
Journal:  J Natl Cancer Inst       Date:  1972-06       Impact factor: 13.506

6.  B.C.G. vaccination and leukemia mortality.

Authors:  L Davignon; P Robillard; P Lemonde; A Frappier
Journal:  Lancet       Date:  1970-09-26       Impact factor: 79.321

7.  Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G.

Authors:  J U Gutterman; E M Hersh; V Rodriguez; K B McCredie; G Mavligit; R Reed; M A Burgess; T Smith; E Gehan; G P Bodey; E J Freireich
Journal:  Lancet       Date:  1974-12-14       Impact factor: 79.321

8.  Regional immunotherapy of lung cancer with intrapleural B.C.G.

Authors:  M F McKneally; C Maver; H W Kausel
Journal:  Lancet       Date:  1976-02-21       Impact factor: 79.321

9.  BCG immunotherapy of pulmonary growths from intravenously transferred rat tumour cells.

Authors:  R W Baldwin; M V Pimm
Journal:  Br J Cancer       Date:  1973-01       Impact factor: 7.640

10.  Response of syngeneic murine lymphomata to immunotherapy in relation to the antigenicity of the tumour.

Authors:  I Parr
Journal:  Br J Cancer       Date:  1972-06       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.